JLab Hear OTC vs Otofonix Encore

The JLab Hear OTC is a budget-friendly OTC hearing aid priced at $100, earning a B grade with a SoundScore of 3.6/5 in HearAdvisor's lab testing. This visible-in-ear device ranks #36 of 65 OTC hearing aids tested, placing it in the top 54% of its category. In our testing, the JLab Hear OTC shows a distinctive performance profile with clear strengths and weaknesses. Music streaming stands out as exceptional, scoring 4.6/5—a remarkable 2.68 points above the category average. Feedback handling also performs excellently at 5.0/5, providing stable amplification without whistling during our standardized challenge motions. These strengths make it particularly well-suited for users who prioritize streaming audio content. However, speech performance presents limitations. Speech in quiet scores 2.1/5, which is 0.67 points below the category average of 2.79. Speech in noise is more constrained at 1.0/5, falling 0.46 points below average. Own-voice comfort also scores low at 1.8/5, which is 0.71 points below the category norm. These results suggest the device may be less effective for primary speech amplification needs compared to alternatives in its price range. The JLab Hear OTC includes rechargeable batteries and supports both iPhone and Android streaming with hands-free functionality. At this price point, competitors like the Elehear Beyond (4.36/5) and Apple AirPods Pro 2 (4.06/5) offer stronger overall sound performance. This device may appeal most to budget-conscious users who value excellent streaming quality and feedback stability over speech enhancement capabilities.

The Otofonix Encore is a behind-the-ear prescription hearing aid priced at $295, placing it in the budget tier of the prescription category. In our lab testing, it earned a C grade with a SoundScore of 2.7/5, ranking 35th out of 36 prescription hearing aids tested. Sound performance presents significant challenges across most metrics. Speech clarity scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.32 and 0.96 points below category averages respectively. Music streaming capability is essentially absent at 0.0/5, and own-voice comfort is notably limited at 0.1/5 in the tuned configuration—2.65 points below the category average. The one bright spot is feedback handling, which scores an excellent 4.7/5. While this falls just 0.01 points below the category average, it represents strong absolute performance that should minimize whistling issues during daily use. This device runs on disposable batteries. At this price point, shoppers should be aware that the RxEars Rxi offers substantially better sound performance (4.09/5) in the same price range. The Otofonix Encore may suit budget-conscious consumers who prioritize feedback stability over speech clarity and streaming features, but our testing suggests most users would benefit from considering higher-performing alternatives within this price tier.